NCT06426745

Brief Summary

Colonoscopy is the current standard method for evaluation of colonic disorders such as colorectal cancer, IBD, polyps, and other conditions.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2022

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 25, 2023

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 19, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 23, 2024

Completed
Last Updated

May 23, 2024

Status Verified

May 1, 2024

Enrollment Period

12 months

First QC Date

May 19, 2024

Last Update Submit

May 19, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • colon cleansing

    to compare the efficacy of split-dose versus single morning administration of PEG solution for colon cleansing in patient undergoing colonoscopy using Boston Bowel Preparation Scale , and to assess the optimal preparation- to-colonoscopy (PC) interval .

    2 hours before Bowel Preparation

Study Arms (2)

Split-dose bowel preparation

EXPERIMENTAL

About 90 participants underwent Split-dose bowel preparation for colonoscopy

Procedure: Bowel preparation

single-dose bowel preparation

EXPERIMENTAL

About 90 participants underwent single-dose bowel preparation for colonoscopy

Procedure: Bowel preparation

Interventions

to compare bowel cleanliness, compliance, tolerability, and patient satisfaction of a single regimen versus a split regimen for colonoscopy.

Also known as: colonoscopy
Split-dose bowel preparationsingle-dose bowel preparation

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • \- All patients undergoing elective colonoscopy

You may not qualify if:

  • Presence of sever renal impairment. (Creatinine clearance \< 30 ml/min or patient on hemodialysis).
  • Sever congestive heart failure (NHYA III or IV).
  • Pregnant woman.
  • History of bowel obstruction or resection.
  • Known allergies to polyethylene glycol.
  • Refusal of consent for the study.
  • Signs of liver cell failure as ascites and hepatic encephalopathy.
  • Electrolytes disturbances

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mansoura university Hospital

Al Mansurah, Egypt

Location

MeSH Terms

Conditions

Colonic NeoplasmsColonic PolypsIrritable Bowel Syndrome

Interventions

CatharticsColonoscopy

Condition Hierarchy (Ancestors)

Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesIntestinal PolypsPolypsPathological Conditions, AnatomicalPathological Conditions, Signs and SymptomsColonic Diseases, Functional

Intervention Hierarchy (Ancestors)

Gastrointestinal AgentsTherapeutic UsesPharmacologic ActionsChemical Actions and UsesEndoscopy, GastrointestinalEndoscopy, Digestive SystemDiagnostic Techniques, Digestive SystemDiagnostic Techniques and ProceduresDiagnosisEndoscopyDiagnostic Techniques, SurgicalDigestive System Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical Procedures

Study Officials

  • Seham Mohammad Abd-AlAdl Seif, Professor

    Internal Medicine Hepatology and Gastroenterology Faculty of Medicine - Mansoura University

    STUDY CHAIR
  • Hany Shabana, M.D

    Hepatology and Gastroenterology Faculty of Medicine - Mansoura University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 19, 2024

First Posted

May 23, 2024

Study Start

November 1, 2022

Primary Completion

October 25, 2023

Study Completion

December 1, 2023

Last Updated

May 23, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations